DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 1 filers reported holding DECIBEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,902 | +27.5% | 494,071 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,492 | +47.3% | 494,071 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $1,013 | -99.9% | 494,071 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,709,000 | -17.8% | 494,071 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $2,080,000 | +38.5% | 494,071 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $1,502,000 | -34.6% | 494,071 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $2,297,000 | -39.7% | 494,071 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $3,809,000 | -10.4% | 494,071 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $4,249,000 | -24.3% | 494,071 | 0.0% | 0.01% | -30.8% |
| Q1 2021 | $5,613,000 | – | 494,071 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $9,545,000 | 2.59% |
| Samsara BioCapital, LLC | 826,422 | $2,512,000 | 0.63% |
| Orbimed Advisors | 4,945,192 | $15,033,000 | 0.24% |
| Alphabet Inc. | 1,636,258 | $4,974,000 | 0.16% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,000,000 | 0.10% |
| Casdin Capital, LLC | 330,000 | $1,003,000 | 0.04% |
| Bronte Capital Management Pty Ltd. | 163,224 | $496,000 | 0.04% |
| MYDA Advisors LLC | 20,000 | $61,000 | 0.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $801,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $124,716,000 | 0.02% |